UnitedHealth blows past estimates, hikes earnings outlook as it reins in costs
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- UnitedHealth reported Q2 adjusted EPS of $6.38 versus the $4.90 analysts expected and revenue of $112.03 billion versus $110.85 billion expected; net income rose to $5.48 billion from $3.41 billion a year earlier
- UnitedHealth raised its 2026 adjusted EPS outlook to $19.50–$20 from a prior >$18.25, maintained revenue guidance of >$439 billion, and CFO Wayne DeVeydt told reporters the company will likely 'do better than that' given the beat
- UnitedHealth is pouring $1.5 billion into AI to speed prior authorizations and flag fraud, waste and abuse; DeVeydt stressed AI tools do not determine whether care is approved or denied
- UnitedHealth's medical benefit ratio improved to 86.7% in Q2 from 89.4% a year ago — beating the 88.5% analysts expected — though DeVeydt said medical costs remain 'elevated over historical levels'
- UnitedHealthcare membership fell 525,000 sequentially to 48.5 million in Q2; the company projects losing roughly 500,000 ACA exchange members and 1.1 million Medicare Advantage members in 2026
- UnitedHealth faces ongoing Department of Justice investigations over its Medicare billing practices, first disclosed roughly a year ago; DeVeydt said the company remains 'supportive' of the probe with no new updates
Why it matters: UnitedHealth's ~7% premarket jump validates its turnaround playbook — restructuring, exiting unprofitable contracts, and $1.5 billion in AI tooling — even as the broader industry wrestles with deferred post-pandemic care and high-cost GLP-1 drugs. But CFO DeVeydt cautioned results reflect pushing down an already-elevated cost base, not a trend reversal, and the company projects losing 1.6 million ACA and Medicare Advantage members in 2026 while a DOJ Medicare billing probe remains open.
